Literature DB >> 61707

Agarose electrophoresis combined with second dimensional Cetavlon precipitation. A new method for demonstration of acidic polysaccharide K antigens.

F Orskov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 61707

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


× No keyword cloud information.
  6 in total

1.  Identification of capsular antigens in Serratia marcescens.

Authors:  H M Aucken; S G Wilkinson; T L Pitt
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli.

Authors:  W F Vann; K Jann
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli.

Authors:  T Russo; J J Brown; S T Jodush; J R Johnson
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Biochemical, genetic, and epidemiologic characterization of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius) strains associated with Brazilian purpuric fever.

Authors:  D J Brenner; L W Mayer; G M Carlone; L H Harrison; W F Bibb; M C Brandileone; F O Sottnek; K Irino; M W Reeves; J M Swenson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

5.  Special O:K:H serotypes among enterotoxigenic E. coli strains from diarrhea in adults and children. Occurrence of the CF (colonization factor) antigen and of hemagglutinating abilities.

Authors:  I Orskov; F Orskov
Journal:  Med Microbiol Immunol       Date:  1977-07-18       Impact factor: 3.402

6.  Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.

Authors:  F Orskov; I Orskov; A Sutton; R Schneerson; W Lin; W Egan; G E Hoff; J B Robbins
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.